Zoetis Inc (ZTS NYSE) stock market data APIs
$118.9249
0.97(0.8%)
as of December 5, 2025
Try our APIs with
free plan!
Zoetis Inc Financial Data Overview
Price chart is built with
Anychart
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1950 and is headquartered in Parsippany, New Jersey.
Prev. Close
118.9249
Open
119.896
High
120.8172
Low
117.4506
52 wk Range
115.25-179.4576
Market Cap
52 584 M
P/E Ratio
19.9747
Shares Outstanding
441 M
Revenue
9 397 M
EPS
1.7
Dividends (Yield)
0.016
Beta
0.971
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Zoetis Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Zoetis Inc data using free add-ons & libraries
Get Zoetis Inc Fundamental Data
Zoetis Inc Fundamental data includes:
- Net Revenue: 9 397 M
- EBITDA: 3 991 M
- Earnings Per Share: 5
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-03
- EPS/Forecast: 1.64
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Zoetis Inc News
New
Notable healthcare headlines for the week: UnitedHealth, Eli Lilly, and Bristol Myers in focus
Wall Street's major averages closed in the green on Friday, as traders assessed fresh inflation data in hopes of gauging the Federal Reserve's monetary policy. The benchmark S&P 500 closed +0.2%, whi...
Earnings are growing at Zoetis (NYSE:ZTS) but shareholders still don't like its prospects
Investors can approximate the average market return by buying an index fund. When you buy individual stocks, you can make higher profits, but you also face the risk of under-performance. That downside...
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
PARSIPPANY, N.J., December 05, 2025--(BUSINESS WIRE)--Zoetis Inc. today announced that Health Canada has approved Portela™ (relfovetmab injection) for the alleviation of pain associated with osteoar...
Zoetis (ZTS) Up 1.7% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Zoetis (ZTS). Shares have added about 1.7% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the rec...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
